FACIT

FACIT operates as a commercialization venture firm dedicated to accelerating oncology innovations. It actively builds companies alongside entrepreneurs, focusing on translating breakthroughs in cancer research into viable solutions. The firm’s strategic approach involves nurturing promising intellectual property within the oncology sector, encompassing areas such as data science and medical technologies, to create new ventures.

Established in 2014 by the Ontario Institute for Cancer Research (OICR), FACIT emerged from the critical insight that a dedicated entity was needed to bridge the gap between academic cancer research and market application. The OICR formed FACIT as a strategic partner to foster a robust commercialization pathway for homegrown oncology discoveries, ensuring that Canadian innovations could attract investment and ultimately reach patients.

FACIT’s efforts benefit oncology innovators and research institutions seeking to commercialize their discoveries, as well as entrepreneurs building new cancer-focused companies. The firm envisions a future where a vibrant ecosystem of oncology ventures, originating from Ontario, delivers significant advancements in patient care globally. Its long-term goal is to scale the commercialization of Canadian cancer research and attract substantial investment into the sector.